# Eidos Therapeutics, a BridgeBio company

Organization · id `cardio:org-eidos-therapeutics-a-bridgebio-company` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=Eidos+Therapeutics%2C+a+BridgeBio+company>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 5 trials in this atlas.

## Technical summary

Sponsor class industry. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Eidos Therapeutics, a BridgeBio company
- Sponsor class: INDUSTRY

## Connected pages

- Sponsors: Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy (`cardio:ct-nct03860935`)
- Sponsors: Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants (`cardio:ct-nct04988386`)
- Sponsors: Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant (`cardio:ct-nct06563895`)
- Sponsors: To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE) (`cardio:ct-nct07116473`)
- Sponsors: Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis (`cardio:ct-nct07695701`)

## Provenance

Content hash: ca3cc9c7ced8ac38aa8aa0d2311583ded98ff09165d9bff6e1779b00cbcccf01
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
